07/04/2023
#VITA (Valore ed Innovazione delle Terapie Avanzate) è un gruppo di aziende farmaceutiche specializzate nel settore delle Terapie Avanzate e coordinato da LS CUBE Studio… Read more
07/04/2023
Il contributo fornito dal Prof. Marè, prof. di Scienza delle Finanze presso l’Università della Tuscia e la Luiss Business School e… Read more
30/08/2022
On 12 August, 2022, Law No. 118 of Aug. 5, 2022, (“Competition Law 2021”), containing provisions aimed at protecting competition… Read more
25/05/2022
Provisions on transparency of relationships between manufacturers, health-related entities and health organizations On 24th May 2022, the so-called “Sunshine Act”… Read more
28/03/2022
1. Per il nostro team di Life Sciences Regulatory & Compliance e 2. Per il nostro team di Privacy &… Read more
03/01/2022
On 23 December 2021, IVASS published a document, in the form of FAQs, aimed at providing insurance intermediaries and companies… Read more
19/08/2021
On 16 July 2021, IVASS published two letters to the market, relating to some clarifications on Provision 111, which entered… Read more
26/07/2021
Provision No. 111 issued by IVASS on 13 July, 2021 entered into force on 25 July 2021. Provision 111 set… Read more
